Human Genome Epidemiology Literature Finder
Records 1 - 28 (of 28 Records) |
Query Trace: Death and BCL2[original query] |
---|
Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer. Cancer biology & therapy 2007 Oct 6 (10): 1553-8. Jain Meenu, Kumar Shaleen, Upadhyay Rohit, Lal Puneeta, Tiwari Anu, Ghoshal Uday C, Mittal Balr |
The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Oct 13 (19): 5790-7. Bachmann Hagen S, Otterbach Friedrich, Callies Rainer, Nückel Holger, Bau Maja, Schmid Kurt W, Siffert Winfried, Kimmig Rain |
No association between the Bcl2-interacting killer (BIK) gene and schizophrenia. Neuroscience letters 2009 Sep 463 (1): 60-3. Ohi Kazutaka, Hashimoto Ryota, Yasuda Yuka, Yamamori Hidenaga, Hori Hiroaki, Saitoh Osamu, Tatsumi Masahiko, Takeda Masatoshi, Iwata Nakao, Ozaki Norio, Kamijima Kunitoshi, Kunugi Hiros |
BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients. Leukemia research 2010 Feb 34 (2): 166-72. Moon Joon Ho, Sohn Sang Kyun, Lee Myung-Hoon, Jang Jun Ho, Kim Kihyun, Jung Chul Won, Kim Dong Hw |
The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009 Jun 20 (6): 1094-9. Lehnerdt G F, Franz P, Bankfalvi A, Grehl S, Kelava A, Nückel H, Lang S, Schmid K W, Siffert W, Bachmann H |
Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy. Cancer science 2012 Aug 103 (8): 1451-9. Gu Shaohua, Wu Qihan, Zhao Xueying, Wu Wenting, Gao Zhiqiang, Tan Xiaoming, Qian Ji, Chen Hongyan, Xie Yi, Jin Li, Han Baohui, Lu Da |
Impact of promoter polymorphisms in key regulators of the intrinsic apoptosis pathway on the outcome of childhood acute lymphoblastic leukemia. Haematologica 2014 Feb 99 (2): 314-21. Sanchez Rocio, St-Cyr Janick, Lalonde Marie-Eve, Healy Jasmine, Richer Chantal, Gagné Vincent, Laverdière Caroline, Silverman Lewis B, Sallan Stephen E, Neuberg Donna, Kutok Jeffery L, Kritikou Ekaterini A, Krajinovic Maja, Sinnett Dani |
Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population. PloS one 2013 8 (8): e72197. Xu Ping, Liu Li, Wang Jianzhong, Zhang Kai, Hong Xiaohua, Deng Qifei, Xiang Jingjun, Zhang Xiaomin, He Meian, Wu Tangchun, Guo Hu |
Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia. PloS one 2014 9 (8): e103435. Soh Sheila Xinxuan, Lim Joshua Yew Suang, Huang John W J, Jiang Nan, Yeoh Allen Eng Juh, Ong S Tio |
Association of BH3 interacting domain death agonist (BID) gene polymorphisms with proteinuria of immunoglobulin A nephropathy. Scandinavian journal of clinical and laboratory investigation 2014 Jun 74 (4): 329-35. Park Hae Jeong, Kim Jong Woo, Cho Byoung-Soo, Chung Joo- |
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 2015 Jan 125 (4): 658-67. Correia Cristina, Schneider Paula A, Dai Haiming, Dogan Ahmet, Maurer Matthew J, Church Amy K, Novak Anne J, Feldman Andrew L, Wu Xiaosheng, Ding Husheng, Meng X Wei, Cerhan James R, Slager Susan L, Macon William R, Habermann Thomas M, Karp Judith E, Gore Steven D, Kay Neil E, Jelinek Diane F, Witzig Thomas E, Nowakowski Grzegorz S, Kaufmann Scott |
Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer. Mitochondrion 2015 Sep . Datta Sayantan, Ray Anindita, Singh Richa, Mondal Pinaki, Basu Analabha, De Sarkar Navonil, Majumder Mousumi, Maiti Guruparasad, Baral Aradhita, Jha Ganga Nath, Mukhopadhyay Indranil, Panda Chinmay, Chowdhury Shantanu, Ghosh Saurabh, Roychoudhury Susanta, Roy Bidy |
Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia. Apoptosis : an international journal on programmed cell death 2015 Aug . Fernandes Ana Teresa G, Rocha Natália P, Vendrame Elena, Russomano Fabio, Grinsztejn Beatriz J, Friedman Ruth K, Pinto Amanda C, Klumb Evandro M, Avvad Elyzabeth, Macedo Jacyara, Martínez-Maza Otoniel, Bonecini-Almeida Maria da Glor |
BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis. Lung cancer (Amsterdam, Netherlands) 2015 Aug . Cho Eun Na, Kim Eun Young, Jung Ji Ye, Kim Arum, Oh In Jae, Kim Young Chul, Chang Yoon S |
An analysis of the sequence of the BAD gene among patients with maturity-onset diabetes of the young (MODY). Journal of pediatric endocrinology & metabolism : JPEM 2016 Dec . Antosik Karolina, Gny? Piotr, Jarosz-Chobot Przemys?awa, My?liwiec Ma?gorzata, Szadkowska Agnieszka, Ma?ecki Maciej, M?ynarski Wojciech, Borowiec Maci |
Genetic variants of BCL2 gene predict clinical outcomes of non-small-cell lung cancer patients treated with platinum-based chemotherapy in a Chinese population. American journal of cancer research 2016 6 (10): 2310-2322. Ding Xi, Qian Ji, Yang Yang, Xu Wen, Liu Di, Su |
Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors. American journal of respiratory and critical care medicine 2016 Sep . Chang I-Shou, Jiang Shih Sheng, Yang James Chih-Hsin, Su Wu-Chou, Chien Li-Hsin, Hsiao Chin-Fu, Lee Jih-Hsiang, Chen Chih-Yi, Chen Chung-Hsing, Chang Gee-Chen, Wang Zhaoming, Lo Fang-Yi, Chen Kuan-Yu, Wang Wen-Chang, Chen Yuh-Min, Huang Ming-Shyan, Tsai Ying-Huang, Su Yu-Chun, Hsieh Wan-Shan, Shih Wen-Chi, Shieh Shwn-Huey, Yang Tsung-Ying, Lan Qing, Rothman Nathaniel, Chen Chien-Jen, Chanock Stephen J, Yang Pan-Chyr, Hsiung Chao |
ATM, BCL2, and TGF? Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients. Genetic testing and molecular biomarkers 2017 Nov . Agostini Lidiane P, Stur Elaine, Garcia Fernanda M, Ventorim Diego P, Dos Reis Raquel S, Dettogni Raquel S, Dos Santos Eldamária V W, Peterle Gabriela T, Maia Lucas L, Mendes Suzanny O, de Carvalho Marcos B, Tajara Eloiza H, de Paula Flavia, Dos Santos Marcelo, da Silva Adriana M A, Louro Iúri Drumo |
Correlation Between BCL2 and Mcl1 Single Nucleotide Polymorphisms and Chemotherapy Response in Jordanian Patients with Colorectal Cancer. Current pharmaceutical biotechnology 2020 Jul . Mhaidat Nizar M, Amawi Haneen, Alzoubi Karem |
[Genetic variations in apoptosis genes are associated with acute adverse events in postoperative rectal cancer patients receiving concurrent chemoradiotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2020 6 42 (5): 376-382. Yin L L, Yang J, Feng Y R, Huang Y, Feng T, Chen J N, Chen H X, Lin D X, Li Y X, Jin J, Tan |
Investigation of INDEL variants in apoptosis: the relevance to gastric cancer. BMC medical genetics 2020 10 21 (1): 207. Cavalcante Giovanna Chaves, de Moraes Milene Raiol, Valente Cristina Maria Duarte, Silva Caio Santos, Modesto Antônio André Conde, de Assumpção Paula Baraúna, de Assumpção Paulo Pimentel, Santos Sidney, Ribeiro-Dos-Santos Ândr |
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. Translational oncology 2021 1 14 (1): 100977. Hodkinson Brendan P, Schaffer Michael, Brody Joshua D, Jurczak Wojciech, Carpio Cecilia, Ben-Yehuda Dina, Avivi Irit, Forslund Ann, Özcan Muhit, Alvarez John, Ceulemans Rob, Fourneau Nele, Younes Anas, Balasubramanian Srir |
Genetic variants in human BCL2L11 (BIM) are associated with ulcerative forms of Buruli ulcer. Emerging microbes & infections 2021 1 10 (1): 223-225. Fevereiro João, Fraga Alexandra G, Capela Carlos, Sopoh Ghislain E, Dossou Ange, Ayelo Gilbert Adjimon, Peixoto Maria João, Cunha Cristina, Carvalho Agostinho, Rodrigues Fernando, Pedrosa Jor |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV. Blood advances 2022 7 6 (18): 5482-5493. Los-de Vries G Tjitske, Stevens Wendy B C, van Dijk Erik, Langois-Jacques Carole, Clear Andrew J, Stathi Phylicia, Roemer Margaretha G M, Mendeville Matias, Hijmering Nathalie J, Sander Birgitta, Rosenwald Andreas, Calaminici Maria, Hoster Eva, Hiddemann Wolfgang, Gaulard Philippe, Salles Gilles, Horn Heike, Klapper Wolfram, Xerri Luc, Burton Catherine, Tooze Reuben M, Smith Alexandra G, Buske Christian, Scott David W, Natkunam Yasodha, Advani Ranjana, Sehn Laurie H, Raemaekers John, Gribben John, Kimby Eva, Kersten Marie José, Maucort-Boulch Delphine, Ylstra Bauke, de Jong Daph |
Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (Bcl-2/Bax) and Proinflammatory Cytokine (TNF-?/IL-8) Genes on the Susceptibility and Progression of Myeloproliferative Neoplasms: A Case-Control Biomarker Study. Current issues in molecular biology 2023 5 45 (5): 3933-3952. Mamdoh S Moawadh, Rashid Mir, Faris J Tayeb, Orooba Asim, Mohammad Fahad Ull |
Genetic variants in BCL-2 family genes influence the risk of non-syndromic cleft lip with or without cleft palate. Birth defects research 2023 12 . Xing Cui, Guirong Zhu, Minxuan Han, Xiaofeng Li, Shu Lou, Changyue Xing, Shuangbo Xu, Yongchu Pan, Lin Wa |
Investigation of Genetic Factors and Clinical Data in Breast Cancer Highlights the Importance of Breastfeeding and Cancer History. Current issues in molecular biology 2023 10 45 (10): 7933-7943. Amanda Mercês, Rebecca da-Silva-Cruz, Caio S Silva, Rommel Burbano, Ândrea Ribeiro-Dos-Santos, Giovanna C Cavalcan |
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study. American journal of hematology 2023 1 . Michot Jean-Marie, Quivoron Cyril, Sarkozy Clémentine, Danu Alina, Lazarovici Julien, Saleh Khalil, El-Dakdouki Yolla, Goldschmidt Vincent, Bigenwald Camille, Dragani Matteo, Bahleda Rastislav, Baldini Capucine, Arfi-Rouche Julia, Martin-Romano Patricia, Tselikas Lambros, Gazzah Anas, Hollebecque Antoine, Lacroix Ludovic, Ghez David, Vergé Veronique, Marzac Christophe, Cotteret Sophie, Rahali Wassila, Soria Jean-Charles, Massard Christophe, Bernard Olivier A, Dartigues Peggy, Camara-Clayette Valérie, Ribrag Vince |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: